The 143rd Annual Meeting of the Pharmaceutical Society of Japan (Sapporo)

Presentation information

Print

Oral Presentation

(A) Pharmaceutical Chemistry

[27E2-pm] Drug design/Chemical biology

Mon. Mar 27, 2023 2:50 PM - 3:50 PM [Room E2]Institute for the Advancement of Higher Education: E308 (Bldg. E: 3F)

Chair: Kenjiro Hanaoka, Makoto Furutachi

3:02 PM - 3:14 PM

[27E2-pm07S] Development of SARS-CoV-2 Main Protease Inhibitors by Fluorine Substitution and Amide Bond Conversion

○Kouki Shinohara1, Nobuyo Higashi Kuwata2, Kohei Tsuji1, Takahiro Ishii1, Takuya Kobayakawa1, Shin-ichiro Hattori2, Naoki Kishimoto3, Nobutoki Takamune3, Shogo Misumi3, Bulut Haydar4, Hironori Hayashi5, Hiroaki Mitsuya2,4, Hirokazu Tamamura1 (1. Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental Univ., 2. National Center for Global Health and Medicine Research Institute, 3. Faculty of Life Sciences, Kumamoto Univ., 4. NCI/NIH, 5. Department of Infectious Diseases, International Research Institute of Disaster Science, Tohoku Univ.)

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.

Password